Titan Nutrition CO
HELIXIR PHARMACEUTICALS - RETATRUTIDE (GLP-3R) 5mg
HELIXIR PHARMACEUTICALS - RETATRUTIDE (GLP-3R) 5mg
Couldn't load pickup availability
Triple-Agonist Technology for Accelerated Fat Loss & Metabolic Reset
It simultaneously activates GLP-1, GIP and Glucagon — the three key pathways of metabolism. The definitive evolution in metabolic management, surpassing Saxenda, Ozempic, Wegovy and Mounjaro.
✓ Accelerated and sustained fat loss without extreme sacrifice
✓ Total control over appetite, anxiety and cravings
✓ Complete metabolic reset with improved insulin sensitivity
✓ Optimization of the expression of fat loss and nutrient partition
✓ Preservation of muscle mass while eliminating the largest amount of body fat
MAIN ACTION
It simultaneously activates the three key pathways of metabolism - GLP-1, GIP and Glucagon - to trigger advanced fat loss, appetite control and maximum energy efficiency. No previous compound has equaled its power.
RESULTS IN RESEARCH
QUALITY AND ORIGIN
Purity greater than 99%, verified by HPLC analysis. Synthesized under pharmaceutical standards in US laboratories. USA
FACT SHEET
MOLECULAR STRUCTURE
Sequence: Synthetic peptide of 44 amino acids
Molecular weight: ~4863 Da
PHARMACOKINETICS
Half-life: ~6-7 days (subcutaneously)
Bioavailability: High
Metabolism: Degradation by peptidases and proteases
Elimination: Mainly renal and by protein catabolism
USE AND ADMINISTRATION (RESEARCH)
Route: Subcutaneous (injection)
Dose under study: 1, 2, 4, 8, 12 mg according to research protocol
Frequency: 1 time per week
Presentation: 5 mg freeze-dried bottle — reconstitute with bacteriostatic water before use
MECHANISM OF ACTION IN KEY SYSTEMS
Brain
It acts on hypothalamic centers to reduce appetite and increase satiety.
Stomach and intestine
Delays gastric emptying and improves satiety signaling.
Pancreas
Improves glucose-dependent insulin secretion and beta cell function.
Skeletal muscle
Improves insulin sensitivity and glucose metabolism.
Liver and adipose tissue
Increases energy expenditure and reduces fat storage.
Cardiovascular system
Improves risk factors and reduces systemic inflammation.
AREAS OF APPLICATION IN RESEARCH
✓ Treatment of obesity and overweight (research)✓ Type 2 diabetes and insulin resistance
✓ Non-alcoholic steatohepatitis (NASH)
✓ Metabolic syndrome
✓ Cardiovascular prevention
WARNINGS AND SECURITY
⚠ Exclusive use in clinical trials.⚠ Common adverse events: nausea, vomiting, diarrhea, constipation.
⚠ Avoid in people with a history of pancreatitis or spinal cord cancer of the thyroid (family history).
⚠ Do not use during pregnancy or lactation.
Share
